Vir Biotechnology, Inc. (VIR)

CIK 1706431 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Vir Biotechnology, Inc..

Recent SEC filings

FiledFormAccession number
Nov 4, 202610-Q0001628280-26-070273
Nov 4, 20268-K0001628280-26-070148
Nov 4, 202640001628280-26-070025
Nov 3, 20261440001959173-26-007669
Nov 2, 20261440001959173-26-007634
Oct 28, 202640001628280-26-067824
Oct 28, 202630001628280-26-067822
Oct 28, 20268-K0001628280-26-067742
Oct 27, 2026SCHEDULE 13G/A0002012383-26-003861
Oct 14, 20268-K0001628280-26-065826
Oct 8, 20268-K0001628280-26-065408
Oct 6, 202630001628280-26-065222
Oct 1, 20268-K0001628280-26-064117
Sep 17, 20261440001959173-26-007020
Sep 9, 20261440001959173-26-006814
Aug 25, 20261440001959173-26-006425
Aug 24, 20261440001959173-26-006413
Aug 21, 20261440001959173-26-006329
Aug 12, 202640001628280-26-056108
Aug 7, 2026SCHEDULE 13G0000093751-26-000556
Aug 5, 20268-K0001628280-26-053351
Aug 5, 202610-Q0001628280-26-053549
Jul 31, 2026SCHEDULE 13G/A0002100121-26-000992
Jul 24, 20268-K0001628280-26-049499
Jun 29, 20261440001959173-26-004947